Edition:
United States

Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

30.25EUR
24 Jul 2017
Change (% chg)

-- (--)
Prev Close
€30.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
100,598
52-wk High
€56.94
52-wk Low
€29.80

Latest Key Developments (Source: Significant Developments)

Ion Beam Applications sees 5-10 pct revenue growth for FY
Wednesday, 5 Jul 2017 12:59am EDT 

July 5 (Reuters) - ION BEAM APPLICATIONS SA ::COMPANY HAS A COMBINED BACKLOG OF FUTURE PROJECT REVENUES IN SERVICE AND EQUIPMENT WORTH ALMOST EUR 1 BILLION.NOW EXPECTS TO REPORT 5-10% REVENUE GROWTH AND A LOW TO MID-SINGLE DIGIT OPERATING MARGIN FOR THE H1 2017 AS WELL AS FOR FY 2017‍​.STILL ASSESSING IMPACT OF DELAYS ON 2018/2019 AND AN UPDATE WILL BE GIVEN AT TIME OF COMPANY'S HALF YEAR RESULTS.COMPANY'S DIVIDEND POLICY REMAINS UNCHANGED..REMAINS CONFIDENT ON ITS PREVIOUS TARGET OF 13 TO 15% REBIT IN THE MID-TERM.DELAYS IN PROJECT EXECUTION ARE NOW BEING EXPERIENCED IN APPROXIMATELY HALF OF ONGOING PROTON THERAPY PROJECTS.DELAYS IN PROJECT EXECUTION BY SEVERAL OF ITS CUSTOMERS HAVE CONTINUED‍​.  Full Article

Ion Beam Applications to install Africa's first proton therapy center
Friday, 28 Apr 2017 01:00am EDT 

April 28 (Reuters) - Ion Beam Applications SA ::To install Africa's first proton therapy center.The typical end-user price for a proteus one system with a maintenance contract is between EUR 35-40 million ($32.6-43.5 million).Contract signed with children's cancer hospital foundation egypt to install a proteus one solution in Cairo, Egypt.  Full Article

IBA FY REBITDA up 26.6 pct at 42.7 mln euros
Thursday, 23 Mar 2017 02:07am EDT 

Ion Beam Applications SA : Reports FY revenue 328.8 million euros ($354.8 million) versus 270.4 million euros a year ago . FY REBITDA is ‍​42.7 million euros versus 33.7 million euros a year ago . FY net result is 24.4‍​ million euros versus 61.2 million euros a year ago . Will propose dividend of 0.29 euros per share . Net cash and cash equivalents at end of year 74.6‍​ million euros versus 81.7 million euros a year ago . Revenue growth guidance maintained at around 15 pct to 20 pct in 2017 and double digit thereafter . Sees REBIT margin guidance of approx. 11 percent to 12 percent in 2017; increasing to 13-15 pct in 2018 and stabilizing at 15 pct by 2020 .30 percent dividend pay-out ratio target maintained for 2017.  Full Article

IBA selected to install new proton therapy center in Charleroi, Belgium
Monday, 20 Feb 2017 01:00am EST 

Ion Beam Applications SA : IBA selected to install new proton therapy center in Charleroi, Belgium .Wallonia region will invest a total of 47 million euros in this research project.  Full Article

IBA signs contract to install Proteus One compact proton therapy center in Abu Dhabi
Tuesday, 27 Sep 2016 01:00am EDT 

Ion Beam Applications SA :Signs contract to install Proteus One compact proton therapy center in Abu Dhabi, UAE.  Full Article

IBA signs contract with Medstar for the purchase of a proton therapy system
Monday, 26 Sep 2016 01:41am EDT 

Ion Beam Applications SA :Announced on Sunday that it signed a contract with Medstar (Shanghai) Leasing Co., Ltd, a subsidiary of Concord Medical Services Holdings Limited, for the purchase, installation and maintenance of a proton therapy system.  Full Article

Ion Beam Applications H1 net profit down at 8.3‍​ million euros
Thursday, 25 Aug 2016 01:00am EDT 

Ion Beam Applications SA : H1 revenue 145.1‍​ million euros versus 121.0 million euros ($136.39 million) year ago . H1 rebitda 18.0‍​ million euros versus 14.6 million euros year ago .H1 net income 8.3‍​ million euros versus 14.5 million euros year ago.  Full Article

IBA invests 2 million US dollars in HIL Applied Medical Ltd.
Tuesday, 23 Aug 2016 01:00am EDT 

Ion Beam Applications SA : ‍​IBA invests in HIL Applied Medical Ltd. to develop laser-based proton therapy system .IBA has invested USD 2 million and is leading HIL’s series C round, together with other investors.  Full Article

IBA wins 80 mln euro plus contract in China
Wednesday, 29 Jun 2016 06:05am EDT 

Ion Beam Applications SA : Signs contract to install proton therapy center in China . Contract worth more than 80 million euros ($88.5 million) and includes a long term service contract . IBA will equip the new center with five treatment rooms, four isocentric-gantry treatment rooms and a fixed-beam treatment room .Qingdao Zhong Jia Lian He Healthcare Management Company Ltd expects to be treating patients at the center by the end of 2018.  Full Article

Ion Beam Applications appointed Soumya Chandramouli as CFO
Thursday, 2 Jun 2016 01:00am EDT 

Ion Beam Applications SA :Soumya Chandramouli appointed as chief financial officer.  Full Article

IBA lowers full year guidance citing project delays

July 5 Belgian medical equipment maker Ion Beam Applications (IBA) cut its 2017 earnings guidance on Wednesday, as delays in customer's projects weighed on revenue.